[Epidemiologic study of Creutzfeldt-Jakob disease from autopsy-confirmed cases]

Yasushi Iwasaki1, Maya Mimuro, Mari Yoshida

  • 1Department of Neurology, Oyamada Memorial Spa Hospital.

Insights

This study analyzed 61 sporadic Creutzfeldt-Jakob disease (CJD) cases in Japan, finding most patients were over 60 and predominantly had the Met/Met prion protein gene polymorphism. The research suggests a high autopsy rate for CJD in the Tokai region.

Area of Science:

  • Epidemiology of prion diseases
  • Neurodegenerative disorders
  • Medical research methodology

Context:

  • Creutzfeldt-Jakob disease (CJD) is a rare, fatal neurodegenerative disease.
  • Understanding the epidemiology of sporadic CJD is crucial for public health.
  • This study focuses on autopsy-confirmed sporadic CJD cases, excluding other forms.

Purpose:

  • To investigate the epidemiologic characteristics of sporadic Creutzfeldt-Jakob disease (CJD) in the Tokai region of Japan.
  • To analyze patient demographics, medical history, and genetic factors (prion protein gene polymorphism).
  • To estimate the autopsy confirmation rate for CJD in the studied region.

Summary:

  • The study examined 61 autopsy-confirmed sporadic CJD cases, with an average age of onset of 66 years.
  • No significant differences in age of onset were observed between males and females.
  • The majority of cases (92%) were homozygous for methionine at codon 129 (Met/Met) of the prion protein gene.
  • Medical history revealed comorbidities like hypertension and diabetes, with a few cases having prior central nervous system operations.
  • The study suggests a CJD autopsy rate exceeding 50% in the Tokai region over the past seven years.

Impact:

  • Provides valuable data on the demographic and genetic profile of sporadic CJD patients in Japan.
  • Highlights the importance of autopsy confirmation in diagnosing CJD.
  • Contributes to understanding the geographical distribution and diagnostic practices for CJD in the Tokai region.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...